Starting Dose of Alprazolam for Panic Attacks
For panic disorder, initiate alprazolam at 0.5 mg three times daily (1.5 mg total daily dose), then titrate upward every 3-4 days by no more than 1 mg per day based on response. 1
Dosing Algorithm
Initial Dosing
- Standard adult dose: 0.5 mg orally three times daily 1
- Elderly, debilitated, or advanced liver disease: 0.25 mg orally 2-3 times daily 2
Titration Strategy
- Increase dose at intervals of 3-4 days in increments of no more than 1 mg per day 1
- Distribute doses evenly throughout waking hours (three or four times daily schedule) to minimize interdose symptoms 1
- Continue titration until panic attacks are substantially reduced or eliminated, intolerance occurs, or maximum dose is reached 1
Target Dosing Range
- Effective range: Most patients respond to 1-10 mg daily, with mean effective doses of 5-6 mg/day 1, 3
- Maximum dose: 10 mg daily (though most patients require ≤4 mg/day) 1
- Research shows both 2 mg and 6 mg daily doses are significantly superior to placebo, with many patients responding adequately to doses under 6 mg 3
Critical Clinical Considerations
Slower titration is advisable for doses exceeding 4 mg/day to allow full pharmacodynamic effect and minimize adverse responses 1. The evidence shows that while higher doses (>4 mg/day) may be necessary for some patients, they carry increased risks of dependence and more difficult discontinuation 1, 4.
Important Caveats
- Onset of action: Antipanic effects typically emerge during the second week of treatment 5
- Dependence risk: Doses >4 mg/day significantly increase difficulty with tapering and withdrawal severity 1, 4
- Not first-line: Despite proven efficacy 6, 7, 8, alprazolam is no longer recommended as first-line treatment due to tolerance, dependence, and abuse potential 4, 9
Monitoring Requirements
- Assess for oversedation and ataxia, particularly in elderly or debilitated patients 1
- Avoid abrupt discontinuation—taper by no more than 0.5 mg every 3 days when discontinuing 1
- Some patients may require even slower tapering rates 1
The evidence consistently demonstrates alprazolam's efficacy for panic disorder, with 59-85% of patients achieving complete remission of panic attacks 5, 7, but the substantial risks associated with long-term benzodiazepine use must be weighed against these benefits in clinical decision-making.